We are live on ! Find out more
TD Asset Management

TD Asset Management Portfolio holdings

AUM $123B
1-Year Est. Return 34.51%
This Fund
S&P 500
This Quarter Est. Return
+19.92%
1 Year Est. Return
+34.51%
3 Year Est. Return
+98.94%
5 Year Est. Return
+122.3%
10 Year Est. Return
+375.56%
AUM
$70.3B
AUM Growth
+$11.2B
Cap. Flow
+$943M
Cap. Flow %
1.34%
Top 10 Hldgs %
27.79%
Holding
1,465
New
101
Increased
629
Reduced
508
Closed
145

Sector Composition

Rank Sector Weight
1 Financials 21.32%
2 Technology 13.98%
3 Communication Services 9.06%
4 Healthcare 8.83%
5 Industrials 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CETV
1201
DELISTED
Central European Media Enterprises Ltd
CETV
$520K ﹤0.01%
147,001
ICPT
1202
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$519K ﹤0.01%
10,837
-4,000
-27% -$309K
ADT icon
1203
ADT
ADT
$5.58B
$515K ﹤0.01%
64,588
HWKN icon
1204
Hawkins
HWKN
$2.67B
$514K ﹤0.01%
24,160
+2,400
+11% +$45.5K
REPL icon
1205
Replimune Group
REPL
$941M
$514K ﹤0.01%
+20,700
New +$366K
NP
1206
DELISTED
Neenah, Inc. Common Stock
NP
$514K ﹤0.01%
10,400
+800
+8% +$38.5K
TBI
1207
Trueblue
TBI
$215M
$513K ﹤0.01%
33,600
-12,600
-27% -$187K
EWA icon
1208
iShares MSCI Australia ETF
EWA
$1.39B
$511K ﹤0.01%
26,540
+603
+2% +$10.6K
IOSP icon
1209
Innospec
IOSP
$2.12B
$510K ﹤0.01%
6,600
TXMD icon
1210
TherapeuticsMD
TXMD
$23.5M
$509K ﹤0.01%
8,149
+550
+7% +$32K
ESPR
1211
DELISTED
Esperion Therapeutics
ESPR
$508K ﹤0.01%
9,900
+400
+4% +$16.7K
RGEN icon
1212
Repligen
RGEN
$7.96B
$504K ﹤0.01%
4,074
+200
+5% +$23.5K
MEDP icon
1213
Medpace
MEDP
$16.1B
$502K ﹤0.01%
5,400
-7,400
-58% -$630K
ARVN icon
1214
Arvinas
ARVN
$518M
$500K ﹤0.01%
14,900
+9,800
+192% +$416K
GBIO
1215
DELISTED
Generation Bio
GBIO
$494K ﹤0.01%
+2,352
New +$524K
BRBR icon
1216
BellRing Brands
BRBR
$1.44B
$492K ﹤0.01%
24,678
EQBK icon
1217
Equity Bancshares
EQBK
$1.04B
$491K ﹤0.01%
28,141
TH icon
1218
Target Hospitality
TH
$1.51B
$490K ﹤0.01%
289,687
-92,413
-24% -$179K
PII icon
1219
Polaris
PII
$3.82B
$487K ﹤0.01%
5,259
-265
-5% -$20.2K
PBYI icon
1220
Puma Biotechnology
PBYI
$404M
$486K ﹤0.01%
46,600
+2,600
+6% +$26.9K
OFG icon
1221
OFG Bancorp
OFG
$2.23B
$484K ﹤0.01%
36,200
-47,800
-57% -$576K
MGEE icon
1222
MGE Energy Inc
MGEE
$3B
$482K ﹤0.01%
+7,478
New +$488K
FBP icon
1223
First Bancorp
FBP
$4.42B
$475K ﹤0.01%
85,000
+29,600
+53% +$160K
GAP
1224
The Gap Inc
GAP
$7.23B
$468K ﹤0.01%
37,098
-4,569
-11% -$41.2K
EPAY
1225
DELISTED
Bottomline Technologies Inc
EPAY
$467K ﹤0.01%
9,200
-1,200
-12% -$53.6K

Similar funds

TD Asset Management's Q2 2020 Portfolio in Review

As of Q2 2020, TD Asset Management held 1,465 positions worth $70.3B, up 19% from $59.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

TD Asset Management's Q2 2020 filing shows 101 new, 629 increased, 508 reduced and 145 closed positions. Its largest new stake was Trane Technologies: 814,180 shares worth $72.4M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $374M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 23% a quarter earlier, followed by Technology and Communication Services.

  • TD Asset Management's largest Q2 2020 buy was Trane Technologies: 814,180 shares worth $72.4M.
  • TD Asset Management added most to Invesco QQQ Trust in Q2 2020, an estimated $650M increase.
  • TD Asset Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $374M.
  • TD Asset Management fully exited VanEck Semiconductor ETF in Q2 2020, selling an estimated $64M.
  • TD Asset Management's ten largest holdings make up 28% of its $70.3B portfolio in Q2 2020.
  • TD Asset Management opened 101 new positions and closed 145 in Q2 2020.
  • TD Asset Management's portfolio value rose 19% quarter-over-quarter to $70.3B.

Based on TD Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.